These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 2504071

  • 1. [Use of pseudomonas immunoglobulin. Indications and results].
    Werdan K, Melnitzki S, Pilz G, Reuschel-Janetschek E.
    Anasth Intensivther Notfallmed; 1989 Jun; 24(3):153-61. PubMed ID: 2504071
    [Abstract] [Full Text] [Related]

  • 2. [Protective effect of Pseudomonas-specific immunoglobulin from the rabbit and of active immunization in experimental Pseudomonas sepsis in mice].
    Trautmann M, Brückner O, Hahn H.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):370-83. PubMed ID: 6215803
    [Abstract] [Full Text] [Related]

  • 3. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
    Meitert E, Sima F, Savulian C, Petrovici M, Chersulick E, Costache G.
    Arch Roum Pathol Exp Microbiol; 1989 Jul; 48(3):237-51. PubMed ID: 2519634
    [Abstract] [Full Text] [Related]

  • 4. [Passive immunotherapy for treatment of endobronchitis in cystic fibrosis].
    Moss RB.
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():42-6; discussion 47. PubMed ID: 8499750
    [Abstract] [Full Text] [Related]

  • 5. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z, Kimmel R, Petersen S, Thomas S, Pier G, Bezabeh B, Luo R, Schreiber JR.
    Vaccine; 2005 May 09; 23(25):3264-71. PubMed ID: 15837231
    [Abstract] [Full Text] [Related]

  • 6. [Experiences with a Pseudomonas immunoglobulin in artificially respirated patients with Pseudomonas pneumonia at a surgical intensive care unit].
    Böhm D.
    Infection; 1987 May 09; 15(1):73-5. PubMed ID: 3106232
    [Abstract] [Full Text] [Related]

  • 7. [The protective effect of anti-Pseudomonas blood preparations].
    Nazarchuk LV, Koval' AI.
    Fiziol Zh (1994); 2001 May 09; 47(6):55-7. PubMed ID: 11962093
    [Abstract] [Full Text] [Related]

  • 8. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ, Gerçeker AA, Koles NL, Pollack M, Pier GB.
    Invest Ophthalmol Vis Sci; 1997 Jun 09; 38(7):1418-25. PubMed ID: 9191605
    [Abstract] [Full Text] [Related]

  • 9. [Supplemental infection therapy with i.v. immunoglobulins (polyvalent IgG and Pseudomonas IgG)--results of an observational case study with 163 patients].
    Pilz G, Kääb S, Bujdoso O, Neumann R, Werdan K.
    Klin Wochenschr; 1991 Jun 09; 69 Suppl 26():178-84. PubMed ID: 1813716
    [Abstract] [Full Text] [Related]

  • 10. [Use of Pseudomonas immunoglobulin in artificially respirated patients at an interdisciplinary surgical intensive care unit].
    Class I, Junginger W, Klöss T.
    Infection; 1987 Jun 09; 15(1):76-9. PubMed ID: 3106233
    [Abstract] [Full Text] [Related]

  • 11. [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia].
    Pennington JE, Pier GB.
    Infection; 1987 Jun 09; 15(1):56-9. PubMed ID: 3106230
    [Abstract] [Full Text] [Related]

  • 12. Pseudomonas immunoglobulin therapy in patients with Pseudomonas sepsis and septic shock.
    Pilz G, Class I, Boekstegers P, Pfeifer A, Müller U, Werdan K.
    Antibiot Chemother (1971); 1991 Jun 09; 44():120-35. PubMed ID: 1801630
    [No Abstract] [Full Text] [Related]

  • 13. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.
    Pennington JE, Pier GB, Sadoff JC, Small GJ.
    Rev Infect Dis; 1986 Jun 09; 8 Suppl 4():S426-33. PubMed ID: 2944209
    [Abstract] [Full Text] [Related]

  • 14. Anti-Pseudomonas immunoglobulin. III. Preliminary clinical evaluation.
    Sakiel S, Schiller B, Buchowicz I, Kotkowska-Tomanek E.
    Arch Immunol Ther Exp (Warsz); 1983 Jun 09; 31(4):517-21. PubMed ID: 6422901
    [Abstract] [Full Text] [Related]

  • 15. [Experiences with a Pseudomonas immunoglobulin in ventilated patients with Pseudomonas pneumonia in a surgical intensive care station].
    Böhm D.
    Infection; 1987 Jun 09; 15 Suppl 2():S64-6. PubMed ID: 3112023
    [Abstract] [Full Text] [Related]

  • 16. Effect of anti-OprF-OprI immunoglobulin on APACHE II score in a porcine two-hit model of hemorrhagic shock/resuscitation and pseudomonas aeruginosa sepsis.
    Haberstroh J, Gilleland HE, von Specht BU.
    Eur Surg Res; 2005 Jun 09; 37(5):265-73. PubMed ID: 16374008
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic administration of anti-PcrV F(ab')(2) in sepsis associated with Pseudomonas aeruginosa.
    Shime N, Sawa T, Fujimoto J, Faure K, Allmond LR, Karaca T, Swanson BL, Spack EG, Wiener-Kronish JP.
    J Immunol; 2001 Nov 15; 167(10):5880-6. PubMed ID: 11698464
    [Abstract] [Full Text] [Related]

  • 18. [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia].
    Pennington JE, Pier GB.
    Infection; 1987 Nov 15; 15 Suppl 2():S47-50. PubMed ID: 3112020
    [Abstract] [Full Text] [Related]

  • 19. Haemodynamic effects during treatment of sepsis and septic shock with immunoglobulins and plasma-pheresis.
    Werdan K, Pilz G, Kääb S.
    Prog Clin Biol Res; 1989 Nov 15; 308():1025-30. PubMed ID: 2780684
    [No Abstract] [Full Text] [Related]

  • 20. Safety, pharmacokinetics, and functional activity of human anti-Pseudomonas aeruginosa monoclonal antibodies in septic and nonseptic patients.
    Saravolatz LD, Markowitz N, Collins MS, Bogdanoff D, Pennington JE.
    J Infect Dis; 1991 Oct 15; 164(4):803-6. PubMed ID: 1910070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.